Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Crossref DOI link: https://doi.org/10.1186/s12943-024-02139-z
Published Online: 2024-10-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Corcoran, Claire
Rani, Sweta
Breslin, Susan
Gogarty, Martina
Ghobrial, Irene M
Crown, John
O’Driscoll, Lorraine
Text and Data Mining valid from 2024-10-01
Version of Record valid from 2024-10-01
Article History
First Online: 1 October 2024